Otto Bock HealthCare, Duderstadt, Germany, (aka Ottobock) has started the process of converting to an SE & Co. KGaA, a type of limited partnership. Otto Bock Holding possesses an 80 percent share in Otto Bock HealthCare and is 100 percent owned by the Näder family.
Following nearly three decades in his role as CEO at Otto Bock HealthCare, Hans Georg Näder, will assume leadership of the supervisory board of the future Ottobock SE & Co. KGaA as chairman of the board.
Näder’s youngest daughter, Georgia, will represent the family on Ottobock’s supervisory board, which is currently being formed. Georgia will be enlisted to the executive board of Otto Bock Holding. She is currently studying business and marketing in Barcelona, Spain.
Näder’s older daughter, Julia, is being appointed to the board of the Ottobock Global Foundation. She is currently completing an internship at Ottobock in Argentina as part of her business studies degree.
In addition, Oliver Scheel will assume the role of CEO on January 15, 2018. Scheel’s appointment marks the first time in Ottobock’s history that a manager from outside the family will take the helm of the company. Scheel is a longtime partner and managing director at consulting company A.T. Kearney and head of the pharma, medical technology and healthcare department.
Also, longtime CFO Harry Wertz will manage the onboarding of the fourth generation of the Näder family at the Ottobock Group and supporting the HGN start-up incubator as well as the Näder Family Office as he continues his role as CEO of Otto Bock Holding.
The head of the Näder Family Office, Stefan Hirsch, will be enlisted to the executive board of Otto Bock Holding as part of the developments within the company.
